Next Article in Journal
Withdrawn Paper: Rajeev Kumar Jha * and Xu Zi-Rong. Review: Biomedical Compounds from Marine Organisms, Marine Drugs 2004, 2, 123-146
Previous Article in Journal
Acetylcholinesterase-Inhibiting Activity of Pyrrole Derivatives from a Novel Marine Gliding Bacterium, Rapidithrix thailandica
Mar. Drugs 2004, 2(3), 123-146; doi:10.3390/md203123

Biomedical Compounds from Marine organisms

1,*  and 2
Received: 17 May 2004 / Accepted: 1 August 2004 / Published: 25 August 2004
View Full-Text   |   Download PDF [121 KB, uploaded 24 February 2015]
Abstract: The Ocean, which is called the ‘mother of origin of life’, is also the source of structurally unique natural products that are mainly accumulated in living organisms. Several of these compounds show pharmacological activities and are helpful for the invention and discovery of bioactive compounds, primarily for deadly diseases like cancer, acquired immuno-deficiency syndrome (AIDS), arthritis, etc., while other compounds have been developed as analgesics or to treat inflammation, etc. The lifesaving drugs are mainly found abundantly in microorganisms, algae and invertebrates, while they are scarce in vertebrates. Modern technologies have opened vast areas of research for the extraction of biomedical compounds from oceans and seas.
Keywords: Biomedical compounds; ocean; anti-cancer metabolite; anti-HIV metabolite Biomedical compounds; ocean; anti-cancer metabolite; anti-HIV metabolite
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Jha, R.K.; Zi-rong, X. Biomedical Compounds from Marine organisms. Mar. Drugs 2004, 2, 123-146.

AMA Style

Jha RK, Zi-rong X. Biomedical Compounds from Marine organisms. Marine Drugs. 2004; 2(3):123-146.

Chicago/Turabian Style

Jha, Rajeev K.; Zi-rong, Xu. 2004. "Biomedical Compounds from Marine organisms." Mar. Drugs 2, no. 3: 123-146.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert